XOMA Reports Third Quarter 2007 Financial Results
November 08, 2007 04:00 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended...
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8
November 01, 2007 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 1, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call...
XOMA to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
October 30, 2007 16:40 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 30, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
Steven Engle Appointed Chairman of XOMA
October 08, 2007 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced the appointment of its Chief Executive...
XOMA to Present At 2007 BIO Investor Forum
October 03, 2007 16:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 3, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, XOMA's Chief...
XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-1 Antibody Designed to Target Diabetes, Rheumatoid Arthritis and Other Inflammatory Diseases
September 12, 2007 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 12, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced the start of a second Phase 1 clinical study of XOMA 052, a potent monoclonal antibody targeting...
XOMA Licenses Antibody Technology to Pfizer
August 28, 2007 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Aug. 28, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that it has licensed to Pfizer Inc., the world's largest research-based biomedical and pharmaceutical...
XOMA Reports Second Quarter 2007 Financial Results
August 08, 2007 16:02 ET
|
XOMA Corporation
BERKELEY, Calif., Aug. 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today reported financial results for the second quarter...
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
August 06, 2007 08:15 ET
|
XOMA Corporation
BERKELEY, Calif., Aug. 6, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics for cancer and inflammatory diseases, today announced...
XOMA to Present At Canaccord Adams Global Growth Conference On August 9, 2007
August 02, 2007 09:00 ET
|
XOMA Corporation
BERKELEY, Calif., Aug. 2, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that David Boyle, XOMA's Chief Financial Officer, is scheduled to present at the Canaccord Adams Global...